Just reported
From GE HealthCare Technologies's results release of 28 de outubro de 2026; its quarterly report has since been filed.
Actual
US$ 5,51B
+7,2% y/y
+4,1% q/q
Guided
—
No guide given
Actual
US$ 1,36
+39% y/y
+9,7% q/q
Guided
—
No guide given
Actual
US$ 805M
+23% y/y
+8,9% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes GE HealthCare Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
As participações na receita são estimativas para nine months ended September 30, 2026, não números de um relatório oficial.
Computed tomography scanners
Scanners use X-rays to create cross-sectional and three-dimensional images that can help clinicians find problems such as tumors, blocked blood vessels, or fractures.
Magnetic resonance scanners
Scanners use magnetic fields to create detailed images of internal body structures, including the brain, heart, and muscles.
Ultrasound systems
Systems use sound waves to create images for diagnosis and monitoring, including during pregnancy, heart examinations, and procedures.
X-ray systems
Fixed, portable, and moving-image X-ray equipment helps clinicians examine bones, lungs, and other parts of the body.
Patient monitors and electrocardiogram devices
Devices measure and display signs such as heart rhythm, blood pressure, and oxygen levels so care teams can track patients.
Contrast agents and radiopharmaceuticals
These medicines are given before or during scans to make certain tissues or biological activity easier to see in images.
Demonstrações financeiras completas →
GE HealthCare makes scanners that create images of the body using X-rays, magnetic fields, or sound waves, along with equipment used to guide procedures and monitor patients. It also sells contrast agents and radioactive imaging drugs that help clinicians interpret scans, and provides equipment maintenance, software, and cloud services. Its software includes tools that use artificial intelligence (AI) to help with image analysis and clinical workflows.
Construído a partir dos próprios documentos de GE HealthCare Technologies Inc. entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
GEHC · Nasdaq · Healthcare · Medical Devices
US$ 83,05+1,5%fechamento 13 de nov.
Números até 30 de setembro de 2026, do 10-Q arquivado em 28 de outubro de 2026
GE HealthCare sells medical imaging scanners and ultrasound systems to hospitals and health systems, plus diagnostic imaging drugs.
Grade A
A faixa sob o preço mostra a nota em cada data, calculada só com os documentos já públicos naquele momento.
Mostrando 2 de 11 trimestres do histórico de notas de GE HealthCare Technologies Inc.. Os outros 9 vão até fevereiro de 2024.